Bladder cancer is a significant healthcare burden with more than 17. 000 deaths in the United States in 2018. Patients who are diagnosed with muscle invasive bladder cancer (MIBC) have a high rate of micro-metastatic disease and have a much poorer prognosis compared with patients who have less advanced lesions. Historically. https://cosmeticssquadets.shop/product-category/repellents/